<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34857010</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>02</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.</ArticleTitle><Pagination><StartPage>867</StartPage><MedlinePgn>867</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">867</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-021-05569-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronavirus disease 2019 (COVID-19) results in debilitating long-term symptoms, often referred to as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), in a substantial subgroup of patients. One of the most prevalent symptoms following COVID-19 is severe fatigue. Prompt delivery of cognitive behavioural therapy (CBT), an evidence-based treatment that has shown benefit in reducing severe fatigue in other conditions, may reduce post-COVID-19 fatigue. Based on an existing CBT protocol, a blended intervention of 17&#x2009;weeks, Fit after COVID, was developed to treat severe fatigue after the acute phase of infection with SARS-CoV-2.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">The ReCOVer study is a multicentre 2-arm randomised controlled trial (RCT) to test the efficacy of Fit after COVID on severe post-infectious fatigue. Participants are eligible if they report severe fatigue 3 up to and including 12&#x2009;months following COVID-19. One hundred and fourteen participants will be randomised to either Fit after COVID or care as usual (ratio 1:1). The primary outcome, the fatigue severity subscale of the Checklist Individual Strength (CIS-fatigue), is assessed in both groups before randomisation (T0), directly post CBT or following care as usual (T1), and at follow-up 6&#x2009;months after the second assessment (T2). In addition, a long-term follow-up (T3), 12&#x2009;months after the second assessment, is performed in the CBT group only. The primary objective is to investigate whether CBT will lead to a significantly lower mean fatigue severity score measured with the CIS-fatigue across the first two follow-up assessments (T1 and T2) as compared to care as usual. Secondary objectives are to determine the proportion of participants no longer being severely fatigued (operationalised in different ways) at T1 and T2 and to investigate changes in physical and social functioning, in the number and severity of somatic symptoms and in problems concentrating across T1 and T2.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">This is the first trial testing a cognitive behavioural intervention targeting severe fatigue after COVID-19. If Fit after COVID is effective in reducing fatigue severity following COVID-19, this intervention could contribute to alleviating the long-term health consequences of COVID-19 by relieving one of its most prevalent and distressing long-term symptoms.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Netherlands Trial Register NL8947 . Registered on 14 October 2020.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuut</LastName><ForeName>T A</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0002-1840-1406</Identifier><AffiliationInfo><Affiliation>Department of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands. t.kuut@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam University Medical Centers, Expert Center for Chronic Fatigue, Department of Medical Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. t.kuut@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldenkamp</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Lung Medicine, Catharina Hospital, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assmann-Schuilwerve</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical Psychology, Jeroen Bosch Hospital, Den Bosch, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braamse</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geerlings</LastName><ForeName>S E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibney</LastName><ForeName>K B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Service, Royal Melbourne Hospital, and Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanaan</LastName><ForeName>R A A</ForeName><Initials>RAA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieuwkerk</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olde Hartman</LastName><ForeName>T C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pau&#xeb;lsen</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prins</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slieker</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Bernhoven, Uden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Vugt</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bleeker-Rovers</LastName><ForeName>C P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Radboud university medical center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keijmel</LastName><ForeName>S P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Radboud university medical center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knoop</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam University Medical Centers, Expert Center for Chronic Fatigue, Department of Medical Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>10430012010025</GrantID><Acronym>ZONMW_</Acronym><Agency>ZonMw</Agency><Country>Netherlands</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Clin Infect Dis. 2023 Oct 5;77(7):1074-1075. doi: 10.1093/cid/ciad399</RefSource><PMID Version="1">37387683</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015928" MajorTopicYN="Y">Cognitive Behavioral Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognitive behavioural therapy</Keyword><Keyword MajorTopicYN="N">Internet therapy</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long-Haul COVID-19 Fatigue</Keyword><Keyword MajorTopicYN="N">Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Randomised controlled trial</Keyword><Keyword MajorTopicYN="N">Study protocol</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34857010</ArticleId><ArticleId IdType="pmc">PMC8637041</ArticleId><ArticleId IdType="doi">10.1186/s13063-021-05569-y</ArticleId><ArticleId IdType="pii">10.1186/s13063-021-05569-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence (NICE) COVID-19 rapid guideline: managing the long-term effects of COVID-19 [Internet] 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett S, Tafuro J, Mayer J, Darlington D, Wong CW, Muntean EA, et al. Clinical features and outcomes of adults with coronavirus disease 2019: A systematic review and pooled analysis of the literature. Int J Clin Pract. 2021;75(3) 10.1111/ijcp.13725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536970</ArticleId><ArticleId IdType="pubmed">32965728</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasani H, Mardi S, Shakerian S, Taherzadeh-Ghahfarokhi N, Mardi P. The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-Analysis of Clinical and Paraclinical Characteristics. BioMed Research International. Hindawi Limited; 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436291</ArticleId><ArticleId IdType="pubmed">32851061</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Zhong Z, Ji P, Li H, Li B, Pang J, et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: A meta-analysis. Fam Med Community Heal. 2020;8(2) 10.1136/fmch-2020-000406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229787</ArticleId><ArticleId IdType="pubmed">32371463</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15(6):e0234765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7310678</ArticleId><ArticleId IdType="pubmed">32574165</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. a systematic review of the current data. Front Med. 2021;8 10.3389/fmed.2021.653516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: Post-viral syndrome post COVID-19. Medical Hypotheses. Churchill Livingstone; 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Heal Behav. 2020;8(2):61&#x2013;69.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L, Ramezani M, Darazam IA, Sagharichi M, Aalipour MA, Ghorbani F, et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol. 2021;27(1):154&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542&#x2013;02020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Guida F, Polesel J, Marcuzzo AV, Capriotti V, D&#x2019;Alessandro A, et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol. 2021:1&#x2013;4 10.1002/alr.22832. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34109765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11(1) 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MHB, Wing YK, Yu MWM, Leung CM, Ma RCW, Kong APS, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors long-term follow-up. Arch Intern Med. 2009;169(22):2142&#x2013;2147.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Morroy G, Keijmel SP, Delsing CE, Bleijenberg G, Langendam M, Timen A, et al. Fatigue following acute Q-fever: A systematic literature review. PLoS ONE. Public Library of Science; 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4880326</ArticleId><ArticleId IdType="pubmed">27223465</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong J, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulme K, Hudson JL, Rojczyk P, Little P, Moss-Morris R. Biopsychosocial risk factors of persistent fatigue after acute infection: a systematic review to inform interventions. J Psychosom Res. 2017;99:120&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">28712416</ArticleId></ArticleIdList></Reference><Reference><Citation>Korenromp IHE, Meeus M, Bleijenberg G. Nederlandstalige definitie van chronische vermoeidheid. [Dutch language area definition of chronic fatigue] Ned Tijdschr Geneeskd. 2012;156(A44003):1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">22510416</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, et al. Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: An11C-(R)-PK11195 PET study. J Nucl Med. 2014;55(6):945&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Journal of Translational Medicine. BioMed Central Ltd; 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Keijmel SP, Saxe J, van der Meer JWM, Nikolaus S, Netea MG, Bleijenberg G, et al. A comparison of patients with Q fever fatigue syndrome and patients with chronic fatigue syndrome with a focus on inflammatory markers and possible fatigue perpetuating cognitions and behaviour. J Psychosom Res. 2015;79(4):295&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">26272528</ArticleId></ArticleIdList></Reference><Reference><Citation>Menting J, Tack CJ, Donders R, Knoop H. Potential Mechanisms Involved in the Effect of Cognitive Behavioral Therapy on Fatigue Severity in Type 1 Diabetes. J Consult Clin Psychol. 2018;86(4):330&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">29648854</ArticleId></ArticleIdList></Reference><Reference><Citation>Menting J, Tack CJ, Bleijenberg G, Donders R, Fortuyn HAD, Fransen J, et al. Is fatigue a disease-specific or generic symptom in chronic medical conditions? Heal Psychol. 2018;37(6):530&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">29781654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiborg JF, Knoop H, Frank LE, Bleijenberg G. Towards an evidence-based treatment model for cognitive behavioral interventions focusing on chronic fatigue syndrome. J Psychosom Res. 2012;72(5):399&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">22469284</ArticleId></ArticleIdList></Reference><Reference><Citation>Keijmel SP, Delsing CE, Bleijenberg G, Van Der Meer JWM, Donders RT, Leclercq M, et al. Effectiveness of long-term doxycycline treatment and cognitive-behavioral therapy on fatigue severity in patients with Q Fever Fatigue Syndrome (Qure Study): A randomized controlled trial. Clin Infect Dis. 2017;64(8):998&#x2013;1005.</Citation><ArticleIdList><ArticleId IdType="pubmed">28329131</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams HJG, Gielissen MFM, Donders RRT, Goedendorp MM, van der Wouw AJ, Verhagen CAHHVM, et al. The efficacy of Internet-based cognitive behavioral therapy for severely fatigued survivors of breast cancer compared with care as usual: A randomized controlled trial. Cancer. 2017;123(19):3825&#x2013;3834.</Citation><ArticleIdList><ArticleId IdType="pubmed">28621820</ArticleId></ArticleIdList></Reference><Reference><Citation>Castell BD, Kazantzis N, Moss-Morris RE. Cognitive behavioral therapy and graded exercise for chronic fatigue syndrome: a meta-analysis. Clin Psychol Sci Pr. 2011;18(4):311&#x2013;324.</Citation></Reference><Reference><Citation>Janse A, Worm-Smeitink M, Bleijenberg G, Donders R, Knoop H. Efficacy of web-based cognitive-behavioural therapy for chronic fatigue syndrome: Randomised controlled trial. Br J Psychiatry. 2018;212(2):112&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">29436329</ArticleId></ArticleIdList></Reference><Reference><Citation>Menting J, Tack CJ, van Bon AC, Jansen HJ, van den Bergh JP, Mol MJTM, et al. Web-based cognitive behavioural therapy blended with face-to-face sessions for chronic fatigue in type 1 diabetes: a multicentre randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5(6):448&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">28462869</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoop H, Van Der Meer JWM, Bleijenberg G. Guided self-instructions for people with chronic fatigue syndrome: Randomised controlled trial. Br J Psychiatry. 2008;193(4):340&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">18827302</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe M, Goldsmith KA, Johnson AL, Chalder T, Walker J, White PD. Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. Lancet Psychiatry. 2015;2(12):1067&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pubmed">26521770</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse A, Nikolaus S, Wiborg JF, Heins M, van der Meer JWM, Bleijenberg G, et al. Long-term follow-up after cognitive behaviour therapy for chronic fatigue syndrome. J Psychosom Res. 2017;97:45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">28606498</ArticleId></ArticleIdList></Reference><Reference><Citation>Raijmakers RPH, Keijmel SP, Breukers EMC, Bleijenberg G, van der Meer JWM, Bleeker-Rovers CP, et al. Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: One-year follow-up of the Qure study. J Psychosom Res. 2019;116:62&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">30654996</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Gessel LD, Abrahams HJG, Prinsen H, Bleijenberg G, Heins M, Twisk J, et al. Are the effects of cognitive behavior therapy for severe fatigue in cancer survivors sustained up to 14 years after therapy? J Cancer Surviv. 2018;12(4):519&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">29651784</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse A, Bleijenberg G, Knoop H. Prediction of long-term outcome after cognitive behavioral therapy for chronic fatigue syndrome. J Psychosom Res. 2019;121:93&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">31006534</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss-Morris R, Spence MJ, Hou R. The pathway from glandular fever to chronic fatigue syndrome: Can the cognitive behavioural model provide the map? Psychol Med. 2011;41(5):1099&#x2013;1107.</Citation><ArticleIdList><ArticleId IdType="pubmed">20663256</ArticleId></ArticleIdList></Reference><Reference><Citation>Worm-Smeitink M, Gielissen M, Bloot L, van Laarhoven HWM, van Engelen BGM, van Riel P, et al. The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength. J Psychosom Res. 2017;98:40&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">28554371</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AW, Tetzlaff JM, G&#xf8;tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346(jan08 15) 10.1136/bmj.e7586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541470</ArticleId><ArticleId IdType="pubmed">23303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaronson NK, Muller M, PDA C. Essink-Bot M-L, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pubmed">9817123</ArticleId></ArticleIdList></Reference><Reference><Citation>Thandi G, Fear NT, Chalder T. A comparison of the Work and Social Adjustment Scale (WSAS) across different patient populations using Rasch analysis and exploratory factor analysis. J Psychosom Res. 2017;92:45&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">27998511</ArticleId></ArticleIdList></Reference><Reference><Citation>Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD Checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD at www.ptsd.va.gov. 2013.</Citation></Reference><Reference><Citation>Steer RA, Cavalieri TA, Leonard DM, Beck AT. Use of the Beck Depression Inventory for Primary Care to Screen for Major Depression Disorders. Gen Hosp Psychiatry. 1999;21(2):106&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">10228890</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Guth D, Steew RA, Ball R. Screening for major depression disorders in medical inpatients with the beck depression inventory for primary care. Behav Res Ther. 1997;35(8):785&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pubmed">9256522</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">9881538</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoop H, Blijenberg G. Het chronisch vermoeidheidssyndroom: behandelprotocol cognitieve gedragstherapie voor cvs. Houten: Bohn Stafleu van Loghum; 2010.</Citation></Reference><Reference><Citation>Abrahams HJG, Gielissen MFM, Goedendorp MM, Berends T, Peters MEWJ, Poort H, et al. A randomized controlled trial of web-based cognitive behavioral therapy for severely fatigued breast cancer survivors (CHANGE-study): Study protocol. BMC Cancer. 2015;15(1) 10.1186/s12885-015-1787-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4619089</ArticleId><ArticleId IdType="pubmed">26500019</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin CM, Belleville G, B&#xe9;langer L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3079939</ArticleId><ArticleId IdType="pubmed">21532953</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen PB, Andrykowski MA, Thors CL. Relationship of Catastrophizing to Fatigue among Women Receiving Treatment for Breast Cancer. J Consult Clin Psychol. 2004;72(2):355&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2562276</ArticleId><ArticleId IdType="pubmed">15065968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray C, Weir W, Stewart D, Miller P, Hyde G. Ways of coping with Chronic Fatigue Syndrome: Development of an illness management questionnaire. Soc Sci Med. 1993;37(3):385&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">8356486</ArticleId></ArticleIdList></Reference><Reference><Citation>Heins MJ, Knoop H, Burk WJ, Bleijenberg G. The process of cognitive behaviour therapy for chronic fatigue syndrome: Which changes in perpetuating cognitions and behaviour are related to a reduction in fatigue? J Psychosom Res. 2013;75(3):235&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">23972412</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins JB, Bleijenberg G, Bazelmans E, Elving LD, De Boo TM, Severens JL, et al. Cognitive behaviour therapy for chronic fatigue syndrome: A multicentre randomised controlled trial. Lancet. 2001;357(9259):841&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pubmed">11265953</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Werf SP, Prins JB, Vercoulen JHMM, Van Der Meer JWM, Bleijenberg G. Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res. 2000;49(5):373&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">11164063</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridges KR, Sanderman R, Van Sonderen E. An English language version of the social support list: Preliminary reliability. Psychol Rep. 2002;90(3 PART 1):1055&#x2013;1058.</Citation><ArticleIdList><ArticleId IdType="pubmed">12090497</ArticleId></ArticleIdList></Reference><Reference><Citation>van Sonderen E. Het meten van sociale steun met de Sociale Steun Lijst-Interacties (SSL-I) en Sociale Steun Lijst-Discrepanties (SSL-D): een handleiding. 2 e dr. Groningen; 2012.</Citation></Reference><Reference><Citation>van der Ploeg E, Mooren TTM, Kleber RJ, van der Velden PG, Brom D. Construct Validation of the Dutch Version of the Impact of Event Scale. Psychol Assess. 2004;16(1).</Citation><ArticleIdList><ArticleId IdType="pubmed">15023089</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanaken L, Scheveneels S, Belmans E, Hermans D. Validation of the Impact of Event Scale With Modifications for COVID-19 (IES-COVID19). Front Psychiatry. 2020;11 10.3389/fpsyt.2020.00738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399230</ArticleId><ArticleId IdType="pubmed">32848918</ArticleId></ArticleIdList></Reference><Reference><Citation>Custers JAE, van den Berg SW, van Laarhoven HWM, Bleiker EMA, Gielissen MFM, Prins JB. The cancer worry scale. Cancer Nurs. 2014;37(1):E44&#x2013;E50.</Citation><ArticleIdList><ArticleId IdType="pubmed">23448956</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Castor Electronic Data Capture. [online] Available at: https://castoredc.com. Castor EDC. 2019.</Citation></Reference><Reference><Citation>Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, van der Meer JWM, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">7965927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: A practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">15016573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiborg JF, Van Bussel J, Van Dijk A, Bleijenberg G, Knoop H. Randomised Controlled Trial of Cognitive Behaviour Therapy Delivered in Groups of Patients with Chronic Fatigue Syndrome. Psychother Psychosom. 2015;84(6):368&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">26402868</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey. Med Care. 1988;26(7).</Citation><ArticleIdList><ArticleId IdType="pubmed">3393032</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180(5):461&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pubmed">11983645</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms [Internet] 2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">11914441</ArticleId></ArticleIdList></Reference><Reference><Citation>Migueles JH, Rowlands AV, Huber F, Sabia S, van Hees VT. GGIR: a research community&#x2013;driven open source R package for generating physical activity and sleep outcomes from multi-day raw accelerometer data. J Meas Phys Behav. 2019;2(3):188&#x2013;196.</Citation></Reference><Reference><Citation>Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep. 2006;29(9):1155&#x2013;1173.</Citation><ArticleIdList><ArticleId IdType="pubmed">17040003</ArticleId></ArticleIdList></Reference><Reference><Citation>Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, et al. The consensus sleep diary: Standardizing prospective sleep self-monitoring. Sleep. 2012;35:287&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3250369</ArticleId><ArticleId IdType="pubmed">22294820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: Development and Final Revision of a Health Status Measure. Care. 1981;19(8):787&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pubmed">7278416</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs HM, Luttik A, De T-OF. Melker RA. The sickness impactprofile; results of an evaluation study of the Dutch version. Ned TijdschrGeneeskd. 1990;134(40):150&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">2234151</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution [Internet]. BMC Health Serv Res. 2003; Available from: http://www.who.int/msa/cidi/listofcon;3(1). 10.1186/1472-6963-3-25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC317472</ArticleId><ArticleId IdType="pubmed">14702202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW, L&#xf6;we B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">20633738</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent E, Petrie KJ, Main J, Weinman J. The Brief Illness Perception Questionnaire. J Psychosom Res. 2006;60(6):631&#x2013;637.</Citation><ArticleIdList><ArticleId IdType="pubmed">16731240</ArticleId></ArticleIdList></Reference><Reference><Citation>de Raaij EJ, Schr&#xf6;der C, Maissan FJ, Pool JJ, Wittink H. Cross-cultural adaptation and measurement properties of the Brief Illness Perception Questionnaire-Dutch Language Version. Man Ther. 2012;17(4):330&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pubmed">22483222</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercoulen JHMM, Swanink CMA, Galama JMD, Fennis JFM, Jongen PJH, Hommes OR, et al. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res. 1998;45(6):507&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">9859853</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennison L, Moss-Morris R, Silber E, Galea I, Chalder T. Cognitive and behavioural correlates of different domains of psychological adjustment in early-stage multiple sclerosis. J Psychosom Res. 2010;69(4):353&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">20846536</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoop H, Van Kessel K, Moss-Morris R. Which cognitions and behaviours mediate the positive effect of cognitive behavioural therapy on fatigue in patients with multiple sclerosis? Psychol Med. 2012;42(1):205&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">21672300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J, De Meirleir K, Duquet W. Kinesiophobia in chronic fatigue syndrome: Assessment and associations with disability. Arch Phys Med Rehabil. 2004;85(10).</Citation><ArticleIdList><ArticleId IdType="pubmed">15468015</ArticleId></ArticleIdList></Reference><Reference><Citation>Kool MB, van Middendorp H, Lumley MA, Schenk Y, Jacobs JW, Bijlsma JW, Geenen R. Lack of understanding in fibromyalgia and rheumatoid arthritis: The Illness Invalidation Inventory (3*I) Ann Rheum Dis. 2010;69(11):1990&#x2013;1995.</Citation><ArticleIdList><ArticleId IdType="pubmed">20498203</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: Assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">18696313</ArticleId></ArticleIdList></Reference><Reference><Citation>Consten C. Measuring Resilience with the Brief Resilience Scale: Factor Structure, Reliability and Validity of the Dutch Version of the BRS (BRSnl) The Netherlands: Enschede; 2016.</Citation></Reference><Reference><Citation>Heins MJ, Knoop H, Bleijenberg G. The role of the therapeutic relationship in cognitive behaviour therapy for chronic fatigue syndrome. Behav Res Ther. 2013;51(7):368&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">23639303</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson NS, Truax P. Clinical Significance: A Statistical Approach to Defining Meaningful Change in Psychotherapy Research. J Consult Clin Psychol. 1991;59(1):12&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">2002127</ArticleId></ArticleIdList></Reference><Reference><Citation>NFU: Richtlijn kwaliteitsborging mensgebonden onderzoek 2019. Nederlandse Federatie van Universitair Medische Centra. 2019.</Citation></Reference><Reference><Citation>Morley S, Dowzer CN. Manual for the Leeds Reliable Change Indicator: Simple Excel applications for the analysis of individual patient and group data. University of Leeds, Leeds, UK. Leeds: University of Leeds; 2014. pp. 1&#x2013;13.</Citation></Reference><Reference><Citation>Cohen J. A Power Primer. Psychol Biulletin. 1992;112(1):155&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">19565683</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim HSL, Hyland KA, Nelson AM, Pinilla-Ibarz J, Sweet K, Gielissen M, et al. Internet-assisted cognitive behavioral intervention for targeted therapy&#x2013;related fatigue in chronic myeloid leukemia: Results from a pilot randomized trial. Cancer. 2020;126(1):174&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6906223</ArticleId><ArticleId IdType="pubmed">31553815</ArticleId></ArticleIdList></Reference><Reference><Citation>Okkersen K, Jimenez-Moreno C, Wenninger S, Daidj F, Glennon J, Cumming S, et al. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. Lancet Neurol. 2018;17(8):671&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pubmed">29934199</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Mcmanimen S, Sunnquist M, Brown A, Newton JL, Strand EB. Examining the Institute of Medicine&#x2019;s Recommendations Regarding Chronic Fatigue Syndrome: Clinical Versus Research Criteria HHS Public Access. J Neurol Psychol. 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5008852</ArticleId><ArticleId IdType="pubmed">27595126</ArticleId></ArticleIdList></Reference><Reference><Citation>Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. 2019;2021(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6953363</ArticleId><ArticleId IdType="pubmed">31577366</ArticleId></ArticleIdList></Reference><Reference><Citation>Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, May AM, Galv&#xe3;o DA, Chinapaw MJ, Steindorf K, Irwin ML, Stuiver MM, Hayes S, Griffith KA, Lucia A, Mesters I, van Weert E, Knoop H, Goedendorp MM, Mutrie N, Daley AJ, McConnachie A, Bohus M, Thorsen L, Schulz KH, Short CE, James EL, Plotnikoff RC, Arbane G, Schmidt ME, Potthoff K, van Beurden M, Oldenburg HS, Sonke GS, van Harten WH, Garrod R, Schmitz KH, Winters-Stone KM, Velthuis MJ, Taaffe DR, van Mechelen W, Kersten MJ, Nollet F, Wenzel J, Wiskemann J, Verdonck-de Leeuw IM, Brug J. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">28006694</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>